HMB for Muscle After 50: Why Older Adults Need It Most
HMB (β-hydroxy-β-methylbutyrate) is a metabolite of the branched-chain amino acid leucine. The body makes only about 0.2–0.4 grams per day from normal protein intake. Where leucine is the main amino-acid signal that turns on muscle protein synthesis, HMB appears to work on the other side of the equation: it slows muscle protein breakdown via inhibition of the ubiquitin–proteasome pathway. That anti-catabolic role is what makes HMB especially relevant for older adults, who experience faster breakdown and a blunted anabolic response to protein — the hallmarks of sarcopenia.
What the Meta-Analyses Actually Show
The largest published meta-analysis to date (Bear et al., American Journal of Clinical Nutrition, 2019; PMID 30982854) pooled 15 RCTs and 2,137 participants across mixed clinical conditions. HMB or HMB-containing supplements produced small but real improvements in skeletal muscle mass (SMD 0.25; 95% CI −0.00 to 0.50) and a clearer effect on muscle strength (SMD 0.31; 95% CI 0.12–0.50). For older adults specifically, Lin et al. (European Geriatric Medicine, 2020; PMID 33034021) pooled 9 RCTs and 448 participants and reported a significant positive effect on fat-free mass (SMD 0.37; 95% CI 0.16–0.58), with the strongest effect when HMB was given as the sole intervention (rather than added to a structured exercise program). Effects are most consistent in frail or bed-rested older adults — the situations where muscle loss is most aggressive.
Effect on sarcopenia vs. placebo in 12-week RCTs
How HMB Differs from Leucine
A common question is why not simply take leucine, since the body converts leucine to HMB. The answer is efficiency and mechanism. Only about 5% of ingested leucine is converted to HMB — you would need roughly 60 grams of leucine daily to generate 3 grams of HMB, an impractical amount that would far exceed protein needs. More importantly, leucine’s primary effect is stimulating mTOR-driven muscle protein synthesis (the anabolic signal), while HMB’s primary effect is slowing muscle protein breakdown (the anti-catabolic signal). These are different pathways. In older adults with “anabolic resistance” (a blunted mTOR response to protein), the anti-catabolic action of HMB may be more achievable than trying to overcome the blunted anabolic response with ever-higher leucine doses.
Who Benefits Most
The benefit is population-specific. In young, well-fed athletes, HMB shows little or no effect — their muscle protein turnover is already well-regulated. The clearer benefit is in adults over 60, especially those who are sedentary, recovering from surgery or hospitalization, frail, or eating below the recommended protein target. Deutz et al. (Clinical Nutrition, 2013; PMID 23514626) randomized older adults (mean age in the 60s; 19 evaluable in the per-protocol analysis) to HMB 3 g/day or placebo around 10 days of complete bed rest. The placebo group lost about 2 kg of lean body mass; the HMB group preserved lean mass, with no significant change. For older adults starting a resistance training program, HMB combined with exercise typically produces greater gains in lean mass and strength than exercise alone.
Proper Dosing Protocol
The established effective dose is 3 g/day of calcium HMB (the most studied form), divided into three 1-gram doses with meals. HMB-free acid (HMB-FA) is a newer form with faster pharmacokinetics — peak blood levels at about 30 minutes vs. 2 hours for calcium HMB — and is sometimes given as a single 3 g daily dose. HMB is not a substitute for adequate protein (1.0–1.2 g/kg/day minimum for older adults, per ESPEN guidance). Loading is not required, but consistent daily use for at least 4–6 weeks is needed to see measurable effects on lean mass. HMB has an excellent safety profile; no significant adverse effects have been reported in published trials.
Sources
- Bear DE, et al. “β-Hydroxy-β-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysis.” American Journal of Clinical Nutrition, 2019. PMID 30982854.
- Lin Z, et al. “Effects of oral administration of β-hydroxy β-methylbutyrate on lean body mass in older adults: a systematic review and meta-analysis.” European Geriatric Medicine, 2020. PMID 33034021.
- Deutz NE, et al. “Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults.” Clinical Nutrition, 2013. PMID 23514626.
- Wu H, et al. “Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis.” Archives of Gerontology and Geriatrics, 2015.
- Volpi E, et al. “Anabolic resistance to dietary protein: an emerging issue in clinical and translational research.” The Journals of Gerontology Series A, 2013 (mechanism support).